Last reviewed · How we verify
Synovian®
At a glance
| Generic name | Synovian® |
|---|---|
| Sponsor | LG Chem |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage (NA)
- Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Synovian® CI brief — competitive landscape report
- Synovian® updates RSS · CI watch RSS
- LG Chem portfolio CI